Location History:
- Tokoyo, JP (1997)
- Tokyo, JP (1998)
Company Filing History:
2 out of 116 
2 out of 2 
2 out of 25 Years Active: 1997-1998
Title: Mitsuuru Emi: Innovator in Human Genetics
Introduction
Mitsuuru Emi is a prominent inventor in the field of human genetics, known for his significant contributions to cancer research. He is based in Tokyo, Japan, and has been instrumental in advancing our understanding of breast and ovarian cancer susceptibility.
Latest Patents
Mitsuuru Emi holds 2 patents, with his latest invention focusing on the linked breast and ovarian cancer susceptibility gene, known as BRCA1. This invention relates to methods and materials used to isolate and detect the BRCA1 gene, which is crucial for diagnosing predisposition to breast and ovarian cancer. The invention also addresses germline and somatic mutations in the BRCA1 gene, providing insights into their role in cancer diagnosis and prognosis. Furthermore, it explores therapeutic approaches for cancers associated with BRCA1 mutations, including gene therapy and drug screening.
Career Highlights
Throughout his career, Mitsuuru Emi has worked with notable organizations, including Myriad Genetics, Inc. and Centre De Recherche Du Chul. His work has significantly impacted the field of genetics and cancer research, leading to advancements in diagnostic and therapeutic strategies.
Collaborations
Mitsuuru Emi has collaborated with esteemed colleagues such as Donna M Shattuck-Eidens and Jacques Simard, contributing to the collective knowledge and research in human genetics.
Conclusion
Mitsuuru Emi's innovative work in identifying and understanding the BRCA1 gene has paved the way for improved cancer diagnostics and therapies. His contributions continue to influence the field of human genetics and cancer research.